Valo Therapeutics Announces Regulatory Approval to Expand Phase I Immuno-oncology Trial into Sarcoma
Four cancer types now included in PeptiCRAd-1 with Pembrolizumab trial: sarcoma, melanoma, triple negative breast cancer and non-small cell lung...
Day: November 29, 2023
TELUS Mental Health Index reveals U.S. workers with depression lose 51 working days in productivity per year
Twenty-seven percent of workers prioritize wellbeing support over salary increase CHICAGO, Nov. 29, 2023 (GLOBE NEWSWIRE) -- TELUS Health today...
Red Light Holland Reports Second Quarter 2024 Results
Cash balance of $16.4 million as at September 30, 2023Revenue of $1.0 million (vs 2022: $0.7 million, an increase of...
FendX Announces Publication of Data on Antimicrobial Properties of a New Nanotechnology Film Formulation that Both Repels and Kills Bacteria
Repel and kill film formulation shows approximately 99.8% reduction in adhesion of bacteria to the surface and at least 99.6%...
Promore Pharma AB intends to carry out a reverse acquisition of PMD Device Solutions AB
STOCKHOLM, SE / ACCESSWIRE / November 29, 2023 / Promore Pharma (STO:PROMO)(FRA:8T0) Promore Pharma AB (publ) (the "Company" or "Promore")...
MedMira Reports FY2023 Fourth Quarter and Year End Financial Results
HALIFAX, NS / ACCESSWIRE / November 28, 2023 / MedMira Inc. (MedMira) (TSXV:MIR), reported today on its financial results for...
Turkeyana Clinic Continues to Invest in Health Tourism
ISTANBUL, TURKEY / ACCESSWIRE / November 28, 2023 / Turkeyana Clinic, a premier healthcare provider known for its cutting-edge treatments...